Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = DNA-inspired janus base nanopieces

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
32 pages, 3538 KiB  
Review
Biomaterial Drug Delivery Systems for Prominent Ocular Diseases
by Avin Sapowadia, Delaram Ghanbariamin, Libo Zhou, Qifa Zhou, Tannin Schmidt, Ali Tamayol and Yupeng Chen
Pharmaceutics 2023, 15(7), 1959; https://doi.org/10.3390/pharmaceutics15071959 - 15 Jul 2023
Cited by 12 | Viewed by 3910
Abstract
Ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, have had a profound impact on millions of patients. In the past couple of decades, these diseases have been treated using conventional techniques but have also presented certain challenges and limitations that affect [...] Read more.
Ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, have had a profound impact on millions of patients. In the past couple of decades, these diseases have been treated using conventional techniques but have also presented certain challenges and limitations that affect patient experience and outcomes. To address this, biomaterials have been used for ocular drug delivery, and a wide range of systems have been developed. This review will discuss some of the major classes and examples of biomaterials used for the treatment of prominent ocular diseases, including ocular implants (biodegradable and non-biodegradable), nanocarriers (hydrogels, liposomes, nanomicelles, DNA-inspired nanoparticles, and dendrimers), microneedles, and drug-loaded contact lenses. We will also discuss the advantages of these biomaterials over conventional approaches with support from the results of clinical trials that demonstrate their efficacy. Full article
(This article belongs to the Special Issue Polymeric Biomaterials for Pharmaceuticals and Biomedical Application)
Show Figures

Figure 1

Back to TopTop